RAP 0.00% 20.5¢ resapp health limited

A new Beginning..., page-2999

  1. 3,464 Posts.
    lightbulb Created with Sketch. 956
    Another milestone achieved with great Home Sleep study data.
    A path toward a plan to create public access to Resapp into Pharmacy's globally.
    TGA Approval for Pediatric use.


    Here we wait....

    FDA approval expected inanimately by RAP management (Could drop any day now).
    US Airforce Program trials bringing in revenue.
    TGA Adult use approval imminent.
    Canadian Approval for Pediatric use of Resapp imminent.
    Singapore Approval for Pediatric use of Resapp imminent.
    China, partnership deal announcement toward a path to commercialization of Resaap in China.

    Sleep app developments and CE mark approval and possible FDA path established once Pediatric use is approved.

    Commencement of US adult trials.

    I am believing that RAP see Canadian and Singapore approvals for Pediatric use this week or very close to it. Adult not long after is expected.

    Access to Resapp DX in the massive markets of Canada and Singapore is also a stamping process upon CE Mark approval just like TGA approval.

    We may also see TGA Approval for Adult use this week.
    That is the path to China that I like.

    I feel a big 2 eek of price sensitive announcements and a couple of Rocket Launches are very close.

    Steady as she goes...
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.